Sudeep Roy, MD
Facial Plastic Surgery · Los Gatos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Roy’s office at (408) 688-2082 to ask if they take your plan before you enroll.
State licence records
2 licences
- Texas Q6786Physician License · since 2015 · expires 2022-02-28Canc Non-RenewalNo board action on this licenceCheck it with the state
- Illinois 036142018Licensed Physician And Surgeon · since 2016 · expires 2023-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$795
Pharmacies billed $795 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
64 generic and fewer than 11 brand-name prescriptions · $795 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diazepam | 13 | $49 | $4 |
Year by year
| 2024 | 67 | 18 | None | None | $795 |
| 2023 | 41 | 18 | 29% (12) | None | $356 |
| 2022 | 78 | 18 | None | 14% | $787 |
| 2021 | 67 | 15 | None | 21% | $703 |
| 2019 | 19 | None | None | None | $242 |
| 2018 | 32 | 14 | None | None | $1,070 |
| 2016 | 37 | 19 | None | None | $778 |
| 2015 | 58 | 35 | 45% (26) | None | $909 |
| 2014 | 77 | 42 | 44% (34) | None | $2,087 |
| 2013 | 62 | 34 | 31% (19) | None | $1,107 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Tranexamic Acid | 15 | $174 | $12 |
| Methylprednisolone | 12 | $134 | $11 |
2021: 2 drugs
| Tranexamic Acid | 13 | $174 | $13 |
| Methylprednisolone | 12 | $129 | $11 |
2018: 1 drug
| Fluticasone Propionate | 18 | $121 | $7 |
2015: 2 drugs
| Cefdinir | 17 | $304 | $18 |
| Hydrocodone-Acetaminophen | 23 | $223 | $10 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 33 | $517 | $16 |
| Cefdinir | 12 | $301 | $25 |
2013: 2 drugs
| Cefdinir | 12 | $323 | $27 |
| Hydrocodone-Acetaminophen | 16 | $164 | $10 |
Money from drug and device companies
$263 in 2025
| 2025 | 2 | 9 | None | $263 |
| 2024 | 3 | 9 | None | $219 |
| 2023 | 1 | 3 | None | $94 |
| 2022 | 1 | 1 | None | $21 |
| 2021 | 3 | 4 | None | $77 |
| 2020 | 6 | 11 | None | $335 |
| 2019 | 6 | 18 | None | $2,022 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $228 | 7 payments
|
| Galderma Laboratories L.P. | None | $36 | 2 payments
|
See all 9 published payments
| Abbvie | Meals · 2025-12-11 | Botox | $10 |
| Abbvie | Meals · 2025-11-19 | Botox | $17 |
| Abbvie | Meals · 2025-11-06 | None | $4 |
| Abbvie | Meals · 2025-10-23 | Botox | $4 |
| Abbvie | Meals · 2025-10-16 | None | $34 |
| Abbvie | Meals · 2025-10-09 | Botox | $30 |
| Galderma Laboratories L.P. | Meals · 2025-05-01 | None | $21 |
| Abbvie | Meals · 2025-04-25 | Botox | $128 |
| Galderma Laboratories L.P. | Meals · 2025-02-21 | None | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $219
| Revance Therapeutics | Daxxify | $101 | 2 payments
|
| Abbvie | Botox | $95 | 6 payments
|
| Galderma Laboratories L.P. | None | $24 | 1 payment
|
2023: $94
| AbbVie | Botox | $94 | 3 payments
|
2022: $21
| Allergan | Botox | $21 | 1 payment
|
2021: $77
| Galderma Laboratories L.P. | None | $39 | 2 payments
|
| Janssen Biotech | Remicade | $20 | 1 payment
|
| Merz North America | None | $18 | 1 payment
|
2020: $335
| Merz North America | Xeomin | $150 | 3 payments
|
| Galderma Laboratories L.P. | None | $79 | 3 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $33 | 2 payments
|
| VYNE Pharmaceuticals | Amzeeq | $28 | 1 payment
|
| Lilly USA | Taltz | $23 | 1 payment
|
| Solta Medical a division of Bausch Health US | None | $23 | 1 payment
|
2019: $2,022
| Apyx Medical | None | $1,639 | 8 payments
|
| Merz North America | Xeomin | $253 | 5 payments
|
| Galderma Laboratories L.P. | None | $53 | 1 payment
|
| Biofrontera | Ameluz | $39 | 2 payments
|
| Lilly USA | Taltz | $22 | 1 payment
|
| Solta Medical a division of Bausch Health US | None | $15 | 1 payment
|
Professional record
- NPI
- 1326338526
- Licence
- IL 036142018, TX Q6786Texas Q6786: Canc Non-RenewalIllinois 036142018: Not Renewed
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207YS0123X (207YS0123X)
- Mailing address
- 800 Pollard Rd Ste A, Los Gatos, CA, 95032
- NPI first listed
- 2011-04-10
- NPI last updated
- 2024-07-02
- NPI record certified
- 2024-07-02
This is when the NPI record was last certified, not a medical board exam.